Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK. Through collaboration and investment, we transform promising medical research breakthroughs into medical therapies that improve patients lives. We have supported more than 50 start-up companies to date, the majority of which were founded by us in collaboration with the inventor and their research institutes. From early-stage seed investment through to expansion capital, Brandon Capital supports life science companies from proof-of-concept through to commercialisation. For more information about Brandon Capital, visit www.brandoncapital.vc
31
Total Investments
21
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
About Brandon Capital
Recent Investments (31)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Undisclosed | •••••• | Jul 2026 | |
| Series A | •••••• | Jul 2024 | |
| Venture Round | •••••• | May 2024 | |
| Series B | •••••• | Apr 2024 | |
| Series A | •••••• | Oct 2023 | |
|
|
Venture Round | •••••• | Jan 2023 |
|
|
Series B | •••••• | Dec 2022 |
|
|
Series A | •••••• | Dec 2022 |
|
|
Grant | •••••• | Jul 2022 |
|
|
Venture Round | •••••• | Jul 2022 |
Latest News
Novartis buys UK biotech Myricx for up to $1.5bn to chase a new cancer-drug class
Thenextweb · Jul 06, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.